Cell-Innovations patented technology
Cell-Innovations is an Australian-owned company involved in developing and commercialising cutting-edge regenerative medical technologies.
Cell-Innovations is engaged in clinical and basic science studies to test the application of autologous Stromal Vascular Fraction (SVF) for various clinical indications.
Cell-Innovations has developed a portfolio of licensed technologies that deliver efficient and reliable separation of Stromal Vascular Fraction (SVF) cells from adipose tissue (a patient’s own fat) in a clinical setting. The autologous SVF is separated and administered to the patient in a single surgical sitting.
The Cell-Innovations proprietary technology has been used in clinical practice since 2012, and looks set to help shape the future of therapeutic approaches to musculoskeletal conditions such as osteoarthritis. Cell-Innovations is at the forefront of improving patients lives with Regenerative Medicine.